Allergy and Immunology · Manalapan, NJ
NPI
1942270616
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
224 Taylor Mills Rd, Suite 106
Manalapan, NJ, 07726
Phone (732) 462-0666
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
2,770 services
Medicare patients, 2024
94
Average age 73
Drug cost, 2024
$392K
695 prescriptions
Company payments, 2025
$328
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carmine J Defusco was code 95165 (treatment - miscellaneous), 1,890 times for 42 patients. In total Carmine J Defusco billed 2,770 services in 16 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95165 Treatment - Miscellaneous | Office | 1,890 | 42 | $11.23 | $21K |
| 95117 Treatment - Miscellaneous | Office | 572 | 40 | $9.72 | $5,562 |
| 99214 Office E&M - Established | Office | 151 | 81 | $102.02 | $15K |
By year: 2022 $54K for 3,040 services; 2023 $47K for 2,511 services; 2024 $49K for 2,770 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carmine J Defusco prescribed most often to Medicare patients was Montelukast Sodium, with 93 prescriptions and refills. In total Carmine J Defusco wrote 695 Medicare prescriptions that cost $392K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 93 | 267 | 27 | $1,265 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 53 | 70 | 27 | $2,360 |
| Desloratadine Generic | 39 | 73 | Under 11 | $1,659 |
| Azelastine Hcl Generic | 36 | 56 | 20 | $778 |
| Azelastine-Fluticasone Azelastine/Fluticasone | 31 | 39 | Under 11 | $3,341 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 29 | 29 | Under 11 | $18K |
| Prednisone Generic | 29 | 29 | 21 | $191 |
| Fluticasone Propionate Generic | 25 | 35 | Under 11 | $1,464 |
| Breo Ellipta Fluticasone/Vilanterol | 21 | 21 | Under 11 | $7,865 |
| Epinephrine Generic | 20 | 20 | 13 | $4,075 |
| Mometasone Furoate Generic | 19 | 56 | Under 11 | $3,774 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 15 | 19 | Under 11 | $13K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 14 | 14 | Under 11 | $107 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 14 | 18 | Under 11 | $1,519 |
| Ventolin Hfa Albuterol Sulfate | 12 | 22 | Under 11 | $2,167 |
Brand drugs: 224 claims; generic drugs: 471 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carmine J Defusco $328 ($328 in general payments such as food, travel and fees) from 7 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $150.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.